Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis

por Gatti-Mays, Margaret, Gulley, James L
Publicado 2021

Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases

por Schlam, Ilana, Gatti-Mays, Margaret E
Publicado 2022

M7824: A promising new strategy to combat cancer immune evasion

por Gatti-Mays, Margaret E., Gulley, James L.
Publicado 2018

Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity

por Sieber, Brendan, Strauss, Julius, Li, Zihai, Gatti-Mays, Margaret E.
Publicado 2022

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

por Wang, Yi, Johnson, Kai Conrad Cecil, Gatti-Mays, Margaret E., Li, Zihai
Publicado 2022

Perspectives of patients undergoing neoadjuvant chemotherapy for breast cancer during the COVID‐19 pandemic

por Gaughan, Alice A., MacEwan, Sarah R., Rush, Laura J., Gatti‐Mays, Margaret E., Pariser, Ashley C., McAlearney, Ann Scheck
Publicado 2023

Natural Killer Cell Recognition and Control of Epithelial Cancers

por de Souza Fernandez Pereira, Marcelo, Carr, David R., Gatti-Mays, Margaret E., Olsen, Mallery R., Setty, Bhuvana A., Shahwan, Kathryn T., Lee, Dean A.
Publicado 2022

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

por Bilusic, Marijo, Heery, Christopher R., Collins, Julie M., Donahue, Renee N., Palena, Claudia, Madan, Ravi A., Karzai, Fatima, Marté, Jennifer L., Strauss, Julius, Gatti-Mays, Margaret E., Schlom, Jeffrey, Gulley, James L.
Publicado 2019

Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies

por Grimm, Michael, Radcliff, Lindsey, Giles, Mariann, Nash, Ryan, Holley, Erin, Panda, Shannon, Brophy, Lynne, Williams, Nicole, Cherian, Mathew, Stover, Daniel, Gatti-Mays, Margaret E., Wesolowski, Robert, Sardesai, Sagar, Sudheendra, Preeti, Reinbolt, Raquel, Ramaswamy, Bhuvaneswari, Pariser, Ashley
Publicado 2022

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced...

por Gatti-Mays, Margaret E., Gameiro, Sofia R., Ozawa, Yohei, Knudson, Karin M., Hicks, Kristin C., Palena, Claudia, Cordes, Lisa M., Steinberg, Seth M., Francis, Deneise, Karzai, Fatima, Lipkowitz, Stanley, Donahue, Renee N., Jochems, Caroline, Schlom, Jeffrey, Gulley, James L.
Publicado 2021

Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls

por Johnson, Kai CC, Grimm, Michael, Sukumar, Jasmine, Schnell, Patrick M., Park, Ko Un, Stover, Daniel G., Jhawar, Sachin R., Gatti-Mays, Margaret, Wesolowski, Robert, Williams, Nicole, Sardesai, Sagar, Pariser, Ashley, Sudheendra, Preeti, Tozbikian, Gary, Ramaswamy, Bhuvaneswari, Doto, Dureti, Cherian, Mathew A.
Publicado 2023

A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker...

por Zimmer, Alexandra S., Nichols, Erin, Cimino-Mathews, Ashley, Peer, Cody, Cao, Liang, Lee, Min-Jung, Kohn, Elise C., Annunziata, Christina M., Lipkowitz, Stanley, Trepel, Jane B., Sharma, Rajni, Mikkilineni, Lekha, Gatti-Mays, Margaret, Figg, William D., Houston, Nicole D., Lee, Jung-Min
Publicado 2019

A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

por Gatti‐Mays, Margaret E., Redman, Jason M., Donahue, Renee N., Palena, Claudia, Madan, Ravi A., Karzai, Fatima, Bilusic, Marijo, Sater, Houssein Abdul, Marté, Jennifer L., Cordes, Lisa M., McMahon, Sheri, Steinberg, Seth M., Orpia, Alanvin, Burmeister, Andrea, Schlom, Jeffrey, Gulley, James L., Strauss, Julius
Publicado 2019

Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses’ health study

por Asad, Sarah, Damicis, Adrienne, Heng, Yujing J., Kananen, Kathryn, Collier, Katharine A., Adams, Elizabeth J., Kensler, Kevin H., Baker, Gabrielle M., Wesolowski, Robert, Sardesai, Sagar, Gatti-Mays, Margaret, Ramaswamy, Bhuvaneswari, Eliassen, A. Heather, Hankinson, Susan E., Tabung, Fred K., Tamimi, Rulla M., Stover, Daniel G.
Publicado 2022

The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

por Johnson, Kai Conrad Cecil, Goldstein, Daniel, Tharakan, Jasmin, Quiroga, Dionisia, Kassem, Mahmoud, Grimm, Michael, Miah, Abdul, Vargo, Craig, Berger, Michael, Sudheendra, Preeti, Pariser, Ashley, Gatti-Mays, Margaret E., Williams, Nicole, Stover, Daniel, Sardesai, Sagar, Wesolowski, Robert, Ramaswamy, Bhuvaneswari, Tozbikian, Gary, Schnell, Patrick M., Cherian, Mathew A.
Publicado 2023

If we build it they will come: targeting the immune response to breast cancer

por Gatti-Mays, Margaret E., Balko, Justin M., Gameiro, Sofia R., Bear, Harry D., Prabhakaran, Sangeetha, Fukui, Jami, Disis, Mary L., Nanda, Rita, Gulley, James L., Kalinsky, Kevin, Abdul Sater, Houssein, Sparano, Joseph A., Cescon, David, Page, David B., McArthur, Heather, Adams, Sylvia, Mittendorf, Elizabeth A.
Publicado 2019

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer

por Disis, Mary L, Adams, Sarah F, Bajpai, Jyoti, Butler, Marcus O, Curiel, Tyler, Dodt, Shelley A, Doherty, Laura, Emens, Leisha A, Friedman, Claire F, Gatti-Mays, Margaret, Geller, Melissa A, Jazaeri, Amir, John, Veena S, Kurnit, Katherine C, Liao, John B, Mahdi, Haider, Mills, Anne, Zsiros, Emese, Odunsi, Kunle
Publicado 2023

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer

por Emens, Leisha A, Adams, Sylvia, Cimino-Mathews, Ashley, Disis, Mary L, Gatti-Mays, Margaret E, Ho, Alice Y, Kalinsky, Kevin, McArthur, Heather L, Mittendorf, Elizabeth A, Nanda, Rita, Page, David B, Rugo, Hope S, Rubin, Krista M, Soliman, Hatem, Spears, Patricia A, Tolaney, Sara M, Litton, Jennifer K
Publicado 2021

Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8(+) T cell antitumor immunity

por Li, Anqi, Chang, Yuzhou, Song, No-Joon, Wu, Xingjun, Chung, Dongjun, Riesenberg, Brian P, Velegraki, Maria, Giuliani, Giuseppe D, Das, Komal, Okimoto, Tamio, Kwon, Hyunwoo, Chakravarthy, Karthik B, Bolyard, Chelsea, Wang, Yi, He, Kai, Gatti-Mays, Margaret, Das, Jayajit, Yang, Yiping, Gewirth, Daniel T, Ma, Qin, Carbone, David, Li, Zihai
Publicado 2022

Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer

por Page, David B., Bear, Harry, Prabhakaran, Sangeetha, Gatti-Mays, Margaret E., Thomas, Alexandra, Cobain, Erin, McArthur, Heather, Balko, Justin M., Gameiro, Sofia R., Nanda, Rita, Gulley, James L., Kalinsky, Kevin, White, Julia, Litton, Jennifer, Chmura, Steven J., Polley, Mei-Yin, Vincent, Benjamin, Cescon, David W., Disis, Mary L., Sparano, Joseph A., Mittendorf, Elizabeth A., Adams, Sylvia
Publicado 2019